# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-027603
Filing Date
2023-08-10
Accepted
2023-08-10 16:50:24
Documents
83
Period of Report
2023-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form10-q.htm iXBRL | 10-Q | 1716537
2 |  | ex31-1.htm | EX-31.1 | 20939
3 |  | ex31-2.htm | EX-31.2 | 20642
4 |  | ex32-1.htm | EX-32.1 | 9846
| Complete submission text file | 0001493152-23-027603.txt |  | 9611297

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL SCHEMA FILE | ocx-20230630.xsd | EX-101.SCH | 75070
6 | XBRL CALCULATION FILE | ocx-20230630_cal.xml | EX-101.CAL | 77401
7 | XBRL DEFINITION FILE | ocx-20230630_def.xml | EX-101.DEF | 383042
8 | XBRL LABEL FILE | ocx-20230630_lab.xml | EX-101.LAB | 579190
9 | XBRL PRESENTATION FILE | ocx-20230630_pre.xml | EX-101.PRE | 496059
77 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-q_htm.xml | XML | 1650067

Mailing Address 15 CUSHING IRVINE CA 92618
Business Address 15 CUSHING IRVINE CA 92618 949-409-7600
Oncocyte Corp (Filer) CIK: 0001642380 (see all company filings)

EIN.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37648 | Film No.: 231160362
SIC: 2835 In Vitro & In Vivo Diagnostic Substances